Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction

脂质体 体内 血管生成 化学 药理学 心肌梗塞 心功能曲线 细胞生物学 癌症研究 生物物理学 医学 病理 生物化学 生物 心脏病学 心力衰竭 生物技术
作者
Siva Sai Krishna Dasa,Ryo Suzuki,Michael F. Gutknecht,Lindsey T. Brinton,Yikui Tian,Erik Michaëlsson,Lennart Lindfors,Alexander L. Klibanov,Brent A. French,Kimberly A. Kelly
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:220 (Pt A): 556-567 被引量:77
标识
DOI:10.1016/j.jconrel.2015.06.017
摘要

Although reperfusion is essential in restoring circulation to ischemic myocardium, it also leads to irreversible events including reperfusion injury, decreased cardiac function and ultimately scar formation. Various cell types are involved in the multi-phase repair process including inflammatory cells, vascular cells and cardiac fibroblasts. Therapies targeting these cell types in the infarct border zone can improve cardiac function but are limited by systemic side effects. The aim of this work was to develop liposomes with surface modifications to include peptides with affinity for cell types present in the post-infarct myocardium. To identify peptides specific for the infarct/border zone, we used in vivo phage display methods and an optical imaging approach: fluorescence molecular tomography (FMT). We identified peptides specific for cardiomyocytes, endothelial cells, myofibroblasts, and c-Kit + cells present in the border zone of the remodeling infarct. These peptides were then conjugated to liposomes and in vivo specificity and pharmacokinetics were determined. As a proof of concept, cardiomyocyte specific (I-1) liposomes were used to deliver a PARP-1 (poly [ADP-ribose] polymerase 1) inhibitor: AZ7379. Using a targeted liposomal approach, we were able to increase AZ7379 availability in the infarct/border zone at 24h post-injection as compared with free AZ7379. We observed ~3-fold higher efficiency of PARP-1 inhibition when all cell types were assessed using I-1 liposomes as compared with negative control peptide liposomes (NCP). When analyzed further, I-1 liposomes had 9-fold and 1.5-fold higher efficiencies in cardiomyocytes and macrophages, respectively, as compared with NCP liposomes. In conclusion, we have developed a modular drug delivery system that can be targeted to cell types of therapeutic interest in the infarct border zone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xy完成签到 ,获得积分10
1秒前
1touzansi完成签到 ,获得积分10
2秒前
科研小书虫的应助被mawenyu采纳,获得10
2秒前
2秒前
GamAooL发布了新的文献求助10
2秒前
LiPengpeng完成签到,获得积分10
3秒前
tutu发布了新的文献求助30
3秒前
李嘉辉完成签到,获得积分10
4秒前
lss完成签到,获得积分10
4秒前
夏日随笔发布了新的文献求助10
5秒前
忆寒发布了新的文献求助10
6秒前
6秒前
李健的粉丝团团长的应助被Eli采纳,获得10
7秒前
Maestro_S的应助被AA采纳,获得10
8秒前
荼蘼发布了新的文献求助10
8秒前
Zz发布了新的文献求助10
8秒前
asd459完成签到,获得积分10
9秒前
晨晨完成签到,获得积分10
9秒前
9秒前
9秒前
完美焦发布了新的文献求助10
10秒前
Rea完成签到,获得积分10
10秒前
闪闪的映波完成签到,获得积分10
11秒前
12秒前
传奇3的应助被primriy采纳,获得10
12秒前
成就完成签到,获得积分10
13秒前
13秒前
深情安青的应助被猫猫大侠采纳,获得10
14秒前
14秒前
万万万完成签到,获得积分10
16秒前
tiantian完成签到,获得积分20
17秒前
18秒前
科研通AI2S的应助被BAEKHYUNLUCKY采纳,获得10
18秒前
19秒前
19秒前
LiWen发布了新的文献求助10
19秒前
19秒前
20秒前
仁仁仁发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241